Search for: "Novo Nordisk Pharmaceutical Industries, Inc."
Results 1 - 20
of 31
Sorted by Relevance
|
Sort by Date
27 Jul 2011, 4:06 pm
The panel invited a response from Plaintiffs-Appellants Novo Nordisk A/S and Novo Nordisk, Inc. [read post]
15 Sep 2008, 10:48 pm
Novo Nordisk Pharmaceutical Industries, Inc. v. [read post]
30 Nov 2011, 8:26 am
Novo Nordisk. [read post]
1 Dec 2017, 11:35 am
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
8 Jul 2011, 11:04 am
IMS Health Inc., ___ U.S. ___, 2011 WL 2472796, at *8 (U.S. [read post]
5 Dec 2011, 7:07 am
NOVO NORDISK A/S, ET AL. [read post]
18 Aug 2010, 12:19 am
Novo Nordisk Pharmaceuticals Pty Ltd; Zetco Pty Ltd v. [read post]
4 Jan 2013, 7:03 am
Novo Nordisk A/S, 132 S.Ct. 1670 (2012). 6. [read post]
18 Nov 2009, 4:57 am
Sun Pharmaceutical Industries Ltd. et al. [read post]
18 Nov 2009, 4:57 am
Sun Pharmaceutical Industries Ltd. et al. [read post]
18 Nov 2009, 4:57 am
Sun Pharmaceutical Industries Ltd. et al. [read post]
1 Jun 2008, 5:08 pm
Novo Nordisk Pharmaceutical Industries, Inc. v. [read post]
28 Dec 2010, 10:58 am
District Court for the Eastern District of Michigan (Southern Division) ruled and issued an Order and Injunction requiring Novo Nordisk, Inc. [read post]
25 Jan 2022, 3:11 pm
There have already been several significant settlements that appear positioned for court approval in 2022, including Twitter ($809.5 million); Teva Pharmaceutical Industries ($420 million); Luckin Coffee ($175 million); Granite Construction ($129 million); Novo Nordisk A/S ($100 million); Stamps.com ($100 million) and NCI Building Systems, Inc. ($100 million). [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
22 Apr 2010, 3:51 am
Teva Pharmaceutical Industries Ltd. et al. [read post]
27 May 2010, 3:20 am
(Patent Docs) PrandiMet (Repaglinide and Metformin) – US: Infringement of patent following Paragraph IV certification: Novo Nordisk Inc. et al. v. [read post]
22 Oct 2015, 8:42 am
IMS Health, Inc., 131 S. [read post]
24 Aug 2011, 12:33 am
General John LaMattian, former head of Pfizer R&D, says industry mergers have harmed R&D efforts (KEI) Non-communicable diseases and IP? [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
